Featured Articles and Interviews
Apr 23, 2025
Biotech and Pharma Market Update: Q1 2025 in Review
More Featured Articles and Inverviews
Press Releases
More Press Releases
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union.